MEDA Pharma GmbH & Co. KG
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 1919-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.medapharma.de
Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
- First Posted Date
- 2009-09-15
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 460
- Registration Number
- NCT00977483
- Locations
- 🇺🇸
Mayo Clinic Arizona, Scottsdale, Arizona, United States
🇳🇱University Hospital Utrecht Department of Internal Medicine, Utrecht, Netherlands
🇺🇸Loyola University Medical Center, Maywood, Illinois, United States
Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses
- First Posted Date
- 2008-10-22
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 258
- Registration Number
- NCT00777127
- Locations
- 🇫🇷
Hospital Sainte Marguerite, Department for Dermatology and Venereology, Pavilion 3, First Floor, Marseille, France
🇫🇷CHU St Jacques, Department for Dermatology, Besancon Cedex, France
🇩🇪Derma Center Vechta, Vechta, Germany
To Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol
- Conditions
- Asthma, Exercise-Induced
- Interventions
- Drug: Combination DSCG and Reproterol
- First Posted Date
- 2008-10-22
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 62
- Registration Number
- NCT00777348
- Locations
- 🇩🇪
Practice Dr. W. Schürmann, Marburg, Germany
🇩🇪Kurmittelhaus der Moderne, Bad Reichenhall, Germany
🇩🇪Asthma Center Buchenhoehe, Berchtesgaden, Germany
Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients
- First Posted Date
- 2008-09-29
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 52
- Registration Number
- NCT00761371
- Locations
- 🇧🇪
Service de Dermatologie Hôpital Erasme, Brussels, Belgium
🇫🇷Service Dermatologie Hopital COCHIN - Pavillon Tarnier, Paris, France
🇫🇷Institut Alfred Fournier, Paris, France
Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation.
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2006-12-07
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 256
- Registration Number
- NCT00408473
- Locations
- 🇫🇷
Patrick KOHAN, 18 rue de la Commanderie, Nancy, France
🇧🇬Department of Cardiology, MHAT Burgas AD, 73 Stefan Stambolov blvd, Burgas, Bulgaria
🇧🇪Hôpital St.-Joseph, Rue de la Duchère 6, Gilly, Belgium
Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2)
- Conditions
- Diabetic Polyneuropathy
- First Posted Date
- 2006-05-22
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 170
- Registration Number
- NCT00328601
- Locations
- 🇷🇺
Chair of Nervous Diseases of IM Sechenov Moscow Medical Academy at City Clinical Hospital, Moscow, Russian Federation
🇮🇱Haddassah Medical Center Ein Kerem, Diabetes Unit, Jerusalem, Israel
🇷🇺Chair of Endocrinology and Diabetology of Russian Medical Academy of Postgraduate Education at Central Clinical Hospital of Ministry of Communication RF, Moscow, Russian Federation
Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions
- Conditions
- Actinic Keratosis
- Interventions
- Drug: Aldara (Imiquimod)Other: Vehicle cream
- First Posted Date
- 2006-02-22
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 12
- Registration Number
- NCT00294320
- Locations
- 🇫🇷
Hopital L'Archet 2, Nice, Cedex 3, France
Aldara for the Treatment of Large and/or Multiple sBCC
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2022-02-22
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 111
- Registration Number
- NCT00189280
- Locations
- 🇫🇷
Service de DermatologieHôpital Dupuytren, Limoges, France
To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial Fibrillation
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 200
- Registration Number
- NCT00189319
- Locations
- 🇫🇷
Hopital Cardiologique, Service de Cardiologique CHR de Lille, Lille, France
A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma
- Conditions
- Basal Cell Carcinoma
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 160
- Registration Number
- NCT00189241
- Locations
- 🇩🇪
Univertätsklinik für Dermatologie und Venerologie, Magedeburg, Germany